Canada NewsWire
TORONTO, Jan. 18, 2019
TORONTO, Jan. 18, 2019 /CNW/ - Simon Langelier, Chairman of the Board, PharmaCielo Ltd. (PCLO), joined Tim Babcock, Managing Director, Capital Formation, TSX Venture Exchange, to open the market. PharmaCielo is headquartered in Canada, with a focus on processing and supplying medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal, and wholly owned subsidiary is PharmaCielo Holdings, headquartered at its nursery and propagation centre located in Rionegro, Colombia. PharmaCielo Ltd. commenced trading on TSX Venture Exchange on January 18, 2019.
SOURCE TMX Group Limited
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2019/18/c9442.html
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member